Cardiac Catheterization in Children with Pulmonary Hypertensive Vascular Disease: Consensus Statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces
暂无分享,去创建一个
S. Harikrishnan | A. Mocumbi | A. Saxena | D. Ivy | A. Lopes | D. Ivy | T. Humpl | I. Adatia | S. Moledina | G. Puri | Patience Udo | S. Haworth | M. D. del Cerro | O. Tamimi | M. J. Cerro | M. A. Dabbagh | H. Banjar | Gabriel F Diaz | Alexandra Heath-Freudenthal | A. Galal | S. Kulkarni | B. Rossouw | L. Caicedo | A. N. Galal
[1] M. Elgendi,et al. Hyperoxia Reduces Oxygen Consumption in Children with Pulmonary Hypertension , 2014, Pediatric Cardiology.
[2] C. Thomson,et al. Pediatric pulmonary hypertension. , 2013, Journal of the American College of Cardiology.
[3] Yoav Dori,et al. Predictors of Catastrophic Adverse Outcomes in Children With Pulmonary Hypertension Undergoing Cardiac Catheterization: A Multi-Institutional Analysis From the Pediatric Health Information Systems Database. , 2015, Journal of the American College of Cardiology.
[4] I. Adatia,et al. Cardiac Catheterization in Children with Pulmonary Hypertensive Vascular Disease , 2015, Pediatric Cardiology.
[5] W. Budts,et al. A different view on predictors of pulmonary hypertension in secundum atrial septal defect. , 2014, International journal of cardiology.
[6] S. Harikrishnan,et al. Repair of Congenital Heart Disease with Associated Pulmonary Hypertension in Children: What are the Minimal Investigative Procedures? Consensus Statement from the Congenital Heart Disease and Pediatric Task Forces, Pulmonary Vascular Research Institute (PVRI) , 2014, Pulmonary circulation.
[7] M. Quail,et al. Real time magnetic resonance assessment of septal curvature accurately tracks acute hemodynamic changes in pediatric pulmonary hypertension , 2014, Journal of Cardiovascular Magnetic Resonance.
[8] Qi-wen Zhou,et al. Patients with Congenital Systemic-to-Pulmonary Shunts and Increased Pulmonary Vascular Resistance: What Predicts Postoperative Survival? , 2014, PloS one.
[9] A. Sabaté Rotés,et al. Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry. , 2014, American journal of respiratory and critical care medicine.
[10] M. Walsh,et al. Measurement of Oxygen Consumption in Children Undergoing Cardiac Catheterization: Comparison Between Mass Spectrometry and the Breath-by-Breath Method , 2014, Pediatric Cardiology.
[11] Alejandro Torres,et al. Safety of Cardiac Catheterization at a Center Specializing in the Care of Patients with Pulmonary Arterial Hypertension , 2013, Pulmonary circulation.
[12] H. Hillege,et al. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension. , 2013, International journal of cardiology.
[13] A. Taylor,et al. Prognostic Significance of Cardiac Magnetic Resonance Imaging in Children With Pulmonary Hypertension , 2013, Circulation. Cardiovascular imaging.
[14] J. Feinstein,et al. Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice , 2013, European Respiratory Journal.
[15] Yuhui Zhang,et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. , 2013, Chest.
[16] R. Barst,et al. Clinical trials in neonates and children: Report of the pulmonary hypertension academic research consortium pediatric advisory committee , 2013, Pulmonary circulation.
[17] R. Friesen,et al. Acute Pulmonary Vasodilator Testing With Inhaled Treprostinil in Children With Pulmonary Arterial Hypertension , 2013, Pediatric Cardiology.
[18] R. Naeije,et al. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease , 2012, European Respiratory Journal.
[19] J. Kreuder,et al. Assessment of pulmonary endothelial function during invasive testing in children and adolescents with idiopathic pulmonary arterial hypertension. , 2012, Journal of the American College of Cardiology.
[20] Hong Wang,et al. Usefulness of intravenous adenosine in idiopathic pulmonary arterial hypertension as a screening agent for identifying long-term responders to calcium channel blockers. , 2012, The American journal of cardiology.
[21] Deepak L. Bhatt,et al. Protocol for vasoreactivity testing with epoprostenol in pulmonary hypertension. , 2012, Critical pathways in cardiology.
[22] R. Barst,et al. Survival in Childhood Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management , 2011, Circulation.
[23] B. McCrindle,et al. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival. , 2011, American heart journal.
[24] S. Harikrishnan,et al. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011 , 2011, Pulmonary circulation.
[25] S. Harikrishnan,et al. Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011 , 2011, Pulmonary circulation.
[26] J. Hoffman. Pulmonary Vascular Resistance and Viscosity: The Forgotten Factor , 2011, Pediatric Cardiology.
[27] D. Ivy,et al. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: Current insights from the magic registry , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[28] A. Saxena,et al. Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart disease suffering from pulmonary artery hypertension. , 2010, Journal of cardiothoracic and vascular anesthesia.
[29] L. Sinoway,et al. Revisiting the role of oxygen therapy in cardiac patients. , 2010, Journal of the American College of Cardiology.
[30] C. Mélot,et al. Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy , 2010, Heart.
[31] A. Bush,et al. Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit , 2010, American heart journal.
[32] T. Delhaas,et al. Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies. , 2010, The American journal of cardiology.
[33] I. Schulze-Neick,et al. Childhood idiopathic pulmonary arterial hypertension: a national cohort study , 2010, Heart.
[34] R. Barst,et al. Vasodilator Testing with Nitric Oxide and/or Oxygen in Pediatric Pulmonary Hypertension , 2010, Pediatric Cardiology.
[35] A. Ribeiro,et al. Adenosine for vasoreactivity testing in pulmonary hypertension: a head-to-head comparison with inhaled nitric oxide. , 2010, Respiratory medicine.
[36] M. Almodovar,et al. Anesthesia considerations for children with pulmonary hypertension. , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[37] C. Dauphin,et al. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. , 2010, Archives of cardiovascular diseases.
[38] S. Bratton,et al. Perioperative complications in children with pulmonary hypertension undergoing general anesthesia with ketamine , 2010, Paediatric anaesthesia.
[39] M. Rabinovitch,et al. Balloon occlusion pulmonary wedge angiography and lung biopsy assessment in the child with a congenital cardiac defect , 2009, Cardiology in the Young.
[40] S. Yoo,et al. Aortopulmonary Collaterals After Bidirectional Cavopulmonary Connection or Fontan Completion: Quantification With MRI , 2009, Circulation. Cardiovascular imaging.
[41] A. Limsuwan,et al. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long‐standing pulmonary hypertension related to congenital heart disease , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[42] Jeffrey L. Anderson,et al. ACCF/AHA Expert Conseusus Document , 2009 .
[43] N. Sekarski,et al. Frequency of severe pulmonary hypertension complicating "isolated" atrial septal defect in infancy. , 2008, The American journal of cardiology.
[44] M. Weiss,et al. Comparison of Calculated with Measured Oxygen Consumption in Children Undergoing Cardiac Catheterization , 2008, Pediatric Cardiology.
[45] R. K. Kumar,et al. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[46] J. Feinstein,et al. Ketamine Does Not Increase Pulmonary Vascular Resistance in Children with Pulmonary Hypertension Undergoing Sevoflurane Anesthesia and Spontaneous Ventilation , 2007, Anesthesia and analgesia.
[47] A. McEwan,et al. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. , 2007, British journal of anaesthesia.
[48] R. Friesen,et al. Perioperative Complications in Children with Pulmonary Hypertension Undergoing Noncardiac Surgery or Cardiac Catheterization , 2007, Anesthesia and analgesia.
[49] B. Lundell,et al. Oxygen consumption in infants and children during heart catheterization , 1996, Pediatric Cardiology.
[50] U. Fakler,et al. Assumed oxygen consumption frequently results in large errors in the determination of cardiac output. , 2005, The Journal of thoracic and cardiovascular surgery.
[51] M. Humbert,et al. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.
[52] J. Moller,et al. The pulmonary vascular response to oxygen and its influence on operative results in children with ventricular septal defect , 1982, Pediatric Cardiology.
[53] F. Van de Werf,et al. Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension. , 2004, European heart journal.
[54] M. Wimmer,et al. Long-term hemodynamic effects of nifedipine on congenital heart disease with eisenmenger's mechanism in children , 1992, Cardiovascular Drugs and Therapy.
[55] D. Webb,et al. Cardiovascular Effects of Acute Oxygen Administration in Healthy Adults , 2003, Journal of cardiovascular pharmacology.
[56] A. Redington,et al. Measured versus estimated oxygen consumption in ventilated patients with congenital heart disease: The validity of predictive equations , 2003, Critical care medicine.
[57] J. Tharakan,et al. Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance. , 2003, Indian heart journal.
[58] W. Hop,et al. Pulmonary arterial wall distensibility assessed by intravascular ultrasound in children with congenital heart disease: an indicator for pulmonary vascular disease? , 2002, Chest.
[59] F. Van de Werf,et al. Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome , 2001, Heart.
[60] A. Kalangos,et al. Inhaled Nitric Oxide Versus Aerosolized Iloprost in Secondary Pulmonary Hypertension in Children With Congenital Heart Disease: Vasodilator Capacity and Cellular Mechanisms , 2001, Circulation.
[61] J. Wilkinson. Haemodynamic calculations in the catheter laboratory , 2001, Heart.
[62] J. Lock,et al. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. , 1999, Journal of the American College of Cardiology.
[63] J. Räsänen,et al. Measured versus predicted oxygen consumption in children with congenital heart disease , 1998, Heart.
[64] P. Trindade,et al. Use of assumed versus measured oxygen consumption for the determination of cardiac output using the Fick principle. , 1998, Catheterization and cardiovascular diagnosis.
[65] P. Clarkson,et al. Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance. , 1989, The American journal of cardiology.
[66] B. Corrin,et al. Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease. , 1988, British heart journal.
[67] D. G. Ritter,et al. Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. , 1987, Circulation.
[68] A Bush,et al. Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease? , 1986, Circulation.
[69] R. Barst. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. , 1986, Chest.
[70] A. Rocchini,et al. Cardiovascular effects of breathing 95 percent oxygen in children with congenital heart disease. , 1983, The American journal of cardiology.
[71] C. Kleinman,et al. Physiologic effects of increasing hemoglobin concentration in left-to-right shunting in infants with ventricular septal defects. , 1982, The New England journal of medicine.
[72] J. F. Keane,et al. Quantitative Analysis of the Pulmonary Wedge Angiogram in Congenital Heart Defects: Correlation with Hemodynamic Data and Morphometric Findings in Lung Biopsy Tissue , 1981, Circulation.
[73] G. Vlahakes,et al. The Pathophysiology of Failure in Acute Right Ventricular Hypertension: Hemodynamic and Biochemical Correlations , 1981, Circulation.
[74] M. Freed,et al. Oximetric detection of intracardiac left-to-right shunts. , 1979, British heart journal.
[75] J. F. Keane,et al. Cardiac output measured by infants and children thermodilution in , 1978 .
[76] J. F. Keane,et al. Cardiac output measured by thermodilution in infants and children. , 1978, The Journal of pediatrics.
[77] D. G. Ritter,et al. Selection of Patients with Truncus Arteriosus for Surgical Correction: Anatomic and Hemodynamic Considerations , 1974, Circulation.
[78] H. Swan,et al. Effect of Breathing Oxygen on Pulmonary Artery Pressure and Pulmonary Vascular Resistance in Patients with Ventricular Septal Defect , 1961, Circulation.